193 related articles for article (PubMed ID: 36296713)
1. Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296713
[TBL] [Abstract][Full Text] [Related]
2. Potent Chlorambucil-Platinum(IV) Prodrugs.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142383
[TBL] [Abstract][Full Text] [Related]
3. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
4. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396859
[TBL] [Abstract][Full Text] [Related]
5. Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173934
[TBL] [Abstract][Full Text] [Related]
6. Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells.
Khoury A; Sakoff JA; Gilbert J; Karan S; Gordon CP; Aldrich-Wright JR
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559273
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic compounds from Laurencia pacifica.
Zaleta-Pinet DA; Holland IP; Muñoz-Ochoa M; Murillo-Alvarez JI; Sakoff JA; van Altena IA; McCluskey A
Org Med Chem Lett; 2014 Dec; 4(1):8. PubMed ID: 26548986
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterisation and potent cytotoxicity of unconventional platinum(iv) complexes with modified lipophilicity.
Deo KM; Sakoff J; Gilbert J; Zhang Y; Aldrich Wright JR
Dalton Trans; 2019 Nov; 48(46):17217-17227. PubMed ID: 31729519
[TBL] [Abstract][Full Text] [Related]
9.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
10. New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes.
Turánek J; Kasná A; Záluská D; Neca J; Kvardová V; Knötigová P; Horváth V; SIndlerová L; Kozubík A; Sova P; Kroutil A; Zák F; Mistr A
Anticancer Drugs; 2004 Jun; 15(5):537-43. PubMed ID: 15166629
[TBL] [Abstract][Full Text] [Related]
11. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
Tabrizi L; Chiniforoshan H
Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidyn-Based Dynamin Inhibitors as Novel Cytotoxic Agents.
Odell LR; Chau N; Russell CC; Young KA; Gilbert J; Robinson PJ; Sakoff JA; McCluskey A
ChemMedChem; 2022 Jan; 17(1):e202100560. PubMed ID: 34590434
[TBL] [Abstract][Full Text] [Related]
14. Platinum(0)-η
Compagno N; Piccolo R; Bortolamiol E; Demitri N; Rizzolio F; Visentin F; Scattolin T
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474631
[TBL] [Abstract][Full Text] [Related]
15. Comparative cytotoxic activity between kaempferol and gallic acid against various cancer cell lines.
Pham HNT; Sakoff JA; Vuong QV; Bowyer MC; Scarlett CJ
Data Brief; 2018 Dec; 21():1033-1036. PubMed ID: 30450396
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity.
Khoury A; Sakoff JA; Gilbert J; Scott KF; Karan S; Gordon CP; Aldrich-Wright JR
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456621
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
19. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR
J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents.
McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
